Bubs Australia, a prominent infant nutrition company, has recently undergone changes in its executive board. Paul Jensen, one of the non-executive directors, has been appointed as the independent chair. This announcement was made following the exit of the previous chair, Katrina Rathie.
Paul Jensen, who has been an integral part of the board since 2023, has now taken on the role of independent chair. Throughout his tenure, Jensen has not only led the company’s audit and risk committee but has also brought to the table more than twenty years of experience. His expertise spans across various industries and includes both ASX-listed and unlisted boards.
Additionally, Joe Coote, who assumed the position of CEO earlier this year, has been appointed to the board as Managing Director (MD). Coote has a deep-seated background in leadership roles, with over two decades of global experience in consumer products, dairy, and infant formula industries.
Expressing his enthusiasm about the future of Bubs and his new role, Jensen said, “I am excited about the future of Bubs and the opportunity to serve as chair and welcome Joe to the board as MD.”
Jensen further highlighted their commitment to advance board evolution throughout the current financial year. This strategic move aims to make certain that the right blend of skills and experience are on board to oversee their corporate strategy, and to align with corporate governance standards.
Who has been appointed as the new independent chair of Bubs Australia?
Paul Jensen, a non-executive director of Bubs Australia, has been appointed as the new independent chair.
Who has joined the board as the managing director?
Joe Coote, CEO of Bubs Australia, has joined the board as the managing director.
What is the main aim of the board evolution at Bubs Australia?
The main aim of the board evolution at Bubs Australia is to ensure a balanced mix of skills and experience to oversee the corporate strategy and comply with corporate governance standards.
